• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌患者肿瘤组织与癌旁组织中差异表达基因的生物信息学分析

Bioinformatics analysis of differentially expressed genes in tumor and paracancerous tissues of patients with lung adenocarcinoma.

作者信息

Yang Rong, Zhou Yuwei, Du Chengli, Wu Yihe

机构信息

Department of Radiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Department of Thoracic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

J Thorac Dis. 2020 Dec;12(12):7355-7364. doi: 10.21037/jtd-20-3453.

DOI:10.21037/jtd-20-3453
PMID:33447425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7797856/
Abstract

BACKGROUND

Lung adenocarcinoma is the main pathological type of non-small cell lung cancer (NSCLC). In this study, we analyzed the gene expression profile of lung adenocarcinoma tumor and paracancerous tissues by bioinformatics to assess the genes and signal pathways related to lung adenocarcinoma.

METHODS

The expression data of GSE7670, GSE27262, and GSE32863 were downloaded from the Gene Expression Omnibus (GEO) database. The three microarray data sets were integrated to obtain common differential expression genes of lung adenocarcinoma tumor and adjacent tissues. The STRING database was used to construct the protein-protein interaction (PPI) network of lung adenocarcinoma and mine the gene modules and core genes in the network, and the online tools, GEPIA and Kaplan-Meier plotter were used to further verify and analyze the core genes.

RESULTS

There were 109 pairs of lung adenocarcinoma tissues and matched paracancerous normal lung tissues in the three data sets. Eighty-three differentially expressed genes were identified, including 16 up-regulated and 67 down-regulated genes, and 60 differentially expressed genes were successfully incorporated into the PPI network complex. Eleven core genes were identified in the PPI network complex, including three up-regulated (, , ) and eight down-regulated genes (, , , , , , , ). These core genes were verified by the GEPIA tumor database. Survival analysis showed that expression of the core genes was significantly related to the prognosis of lung adenocarcinoma. KEGG pathway analysis of core genes showed six genes (, , , , , ) were significantly enriched in the PI3K-Akt signaling-pathway (P=1.62E-06).

CONCLUSIONS

By analyzing the differential expression genes of lung adenocarcinoma and paracancerous normal tissues with bioinformatics, 11 genes with significant differential expression and significant influence on prognosis were identified. The findings may provide new concepts for developing diagnosis and treatment targets and prognosis markers for lung adenocarcinoma.

摘要

背景

肺腺癌是非小细胞肺癌(NSCLC)的主要病理类型。在本研究中,我们通过生物信息学分析肺腺癌肿瘤组织和癌旁组织的基因表达谱,以评估与肺腺癌相关的基因和信号通路。

方法

从基因表达综合数据库(GEO)下载GSE7670、GSE27262和GSE32863的表达数据。整合这三个微阵列数据集以获得肺腺癌肿瘤组织和相邻组织的共同差异表达基因。使用STRING数据库构建肺腺癌的蛋白质-蛋白质相互作用(PPI)网络,并挖掘网络中的基因模块和核心基因,使用在线工具GEPIA和Kaplan-Meier绘图仪对核心基因进行进一步验证和分析。

结果

三个数据集中共有109对肺腺癌组织及匹配的癌旁正常肺组织。鉴定出83个差异表达基因,其中16个上调基因和67个下调基因,60个差异表达基因成功纳入PPI网络复合体。在PPI网络复合体中鉴定出11个核心基因,包括3个上调基因(、、)和8个下调基因(、、、、、、、)。这些核心基因通过GEPIA肿瘤数据库得到验证。生存分析表明,核心基因的表达与肺腺癌的预后显著相关。对核心基因的KEGG通路分析表明,6个基因(、、、、、)在PI3K-Akt信号通路中显著富集(P = 1.62E-06)。

结论

通过生物信息学分析肺腺癌与癌旁正常组织的差异表达基因,鉴定出11个差异表达显著且对预后有显著影响的基因。这些发现可能为开发肺腺癌的诊断和治疗靶点及预后标志物提供新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a60/7797856/72065edfbe16/jtd-12-12-7355-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a60/7797856/3b6d6d84cf39/jtd-12-12-7355-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a60/7797856/0b353616fa14/jtd-12-12-7355-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a60/7797856/7c0d63915a77/jtd-12-12-7355-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a60/7797856/14b8c0e05add/jtd-12-12-7355-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a60/7797856/72065edfbe16/jtd-12-12-7355-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a60/7797856/3b6d6d84cf39/jtd-12-12-7355-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a60/7797856/0b353616fa14/jtd-12-12-7355-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a60/7797856/7c0d63915a77/jtd-12-12-7355-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a60/7797856/14b8c0e05add/jtd-12-12-7355-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a60/7797856/72065edfbe16/jtd-12-12-7355-f5.jpg

相似文献

1
Bioinformatics analysis of differentially expressed genes in tumor and paracancerous tissues of patients with lung adenocarcinoma.肺腺癌患者肿瘤组织与癌旁组织中差异表达基因的生物信息学分析
J Thorac Dis. 2020 Dec;12(12):7355-7364. doi: 10.21037/jtd-20-3453.
2
Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis.运用综合生物信息学分析鉴定导致非小细胞肺癌预后不良的基因和通路。
Transl Cancer Res. 2022 Apr;11(4):710-724. doi: 10.21037/tcr-21-1986.
3
Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.通过综合分析鉴定血管性血友病因子作为肺腺癌的一种新型生物标志物
Front Oncol. 2021 Apr 22;11:639600. doi: 10.3389/fonc.2021.639600. eCollection 2021.
4
Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.通过生物信息学分析鉴定肺腺癌中具有预后价值的关键基因和潜在的肿瘤抑制因子。
BMC Cancer. 2021 May 26;21(1):616. doi: 10.1186/s12885-021-08308-3.
5
Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma.交互式验证分析多种测序数据,以鉴定肺腺癌的潜在生物标志物。
Biomed Res Int. 2020 Oct 1;2020:8931419. doi: 10.1155/2020/8931419. eCollection 2020.
6
[Spindle assembly checkpoint complex-related genes TTK and MAD2L1 are over-expressed in lung adenocarcinoma: a big data and bioinformatics analysis].[纺锤体组装检查点复合物相关基因TTK和MAD2L1在肺腺癌中过表达:大数据与生物信息学分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Oct 30;40(10):1422-1431. doi: 10.12122/j.issn.1673-4254.2020.10.07.
7
Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.基于生物信息学分析鉴定肺腺癌的关键基因和生物学通路。
Mol Cell Biochem. 2021 Feb;476(2):931-939. doi: 10.1007/s11010-020-03959-5. Epub 2020 Nov 1.
8
Exploration of estrogen receptor-associated hub genes and potential molecular mechanisms in non-smoking females with lung adenocarcinoma using integrated bioinformatics analysis.运用综合生物信息学分析探索雌激素受体相关枢纽基因及非吸烟女性肺腺癌潜在分子机制
Oncol Lett. 2019 Nov;18(5):4605-4612. doi: 10.3892/ol.2019.10845. Epub 2019 Sep 10.
9
Identification of core genes and clinical outcomes in tumors originated from endoderm (gastric cancer and lung carcinoma) via bioinformatics analysis.通过生物信息学分析鉴定源于内胚层的肿瘤(胃癌和肺癌)的核心基因和临床结局。
Medicine (Baltimore). 2021 Mar 26;100(12):e25154. doi: 10.1097/MD.0000000000025154.
10
Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis.通过综合生物信息学分析筛选与非小细胞肺癌预后相关的枢纽基因
Transl Cancer Res. 2020 Nov;9(11):7149-7164. doi: 10.21037/tcr-20-1073.

引用本文的文献

1
Missense mutations of GPER1 in breast invasive carcinoma: Exploring gene expression, signal transduction and immune cell infiltration with insights from cellular pharmacology.乳腺浸润性癌中GPER1的错义突变:从细胞药理学角度探索基因表达、信号转导和免疫细胞浸润
Biomed Rep. 2024 Nov 29;22(2):22. doi: 10.3892/br.2024.1900. eCollection 2025 Feb.
2
Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.采用TruSight肿瘤500检测法对非小细胞肺癌(NSCLC)肿瘤进行基因组分析,可广泛覆盖具有临床可操作性的基因组改变,并检测基因组改变、肿瘤突变负荷(TMB)和程序性死亡受体配体1(PD-L1)之间已知和新发现的关联。
Front Oncol. 2024 Nov 27;14:1473327. doi: 10.3389/fonc.2024.1473327. eCollection 2024.
3

本文引用的文献

1
Elemental and mutational analysis of lung tissue in lung adenocarcinoma patients.肺腺癌患者肺组织的元素及突变分析
Transl Lung Cancer Res. 2019 Nov;8(Suppl 3):S224-S234. doi: 10.21037/tlcr.2019.08.18.
2
Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis.胶原蛋白1A1(COL1A1)是肝细胞癌发生和转移的可靠生物标志物及潜在治疗靶点。
Cancers (Basel). 2019 Jun 7;11(6):786. doi: 10.3390/cancers11060786.
3
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.
Identification of key genes and biological pathways in lung adenocarcinoma by integrated bioinformatics analysis.通过综合生物信息学分析鉴定肺腺癌中的关键基因和生物学通路
World J Clin Cases. 2023 Aug 16;11(23):5504-5518. doi: 10.12998/wjcc.v11.i23.5504.
4
Small Extracellular Vesicle-Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma.小细胞外囊泡衍生的 vWF 诱导肿瘤细胞和内皮细胞之间的正反馈环,促进肝癌血管生成和转移。
Adv Sci (Weinh). 2023 Sep;10(26):e2302677. doi: 10.1002/advs.202302677. Epub 2023 Jun 30.
5
Downregulation of Claudin5 promotes malignant progression and radioresistance through Beclin1-mediated autophagy in esophageal squamous cell carcinoma.Claudin5 的下调通过 Beclin1 介导的自噬促进食管鳞癌的恶性进展和放射抵抗。
J Transl Med. 2023 Jun 11;21(1):379. doi: 10.1186/s12967-023-04248-7.
6
LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.长链非编码 RNA LINC00511 通过海绵吸附 miR-126-5p/miR-218-5p 促进肺腺癌 COL1A1 介导的增殖和转移。
BMC Pulm Med. 2022 Jul 16;22(1):272. doi: 10.1186/s12890-022-02070-3.
7
Role of von Willebrand factor in the angiogenesis of lung adenocarcinoma.血管性血友病因子在肺腺癌血管生成中的作用。
Oncol Lett. 2022 Jun;23(6):198. doi: 10.3892/ol.2022.13319. Epub 2022 May 5.
8
Identification of key genes and biological pathways in Chinese lung cancer population using bioinformatics analysis.利用生物信息学分析鉴定中国肺癌人群中的关键基因和生物通路。
PeerJ. 2022 Jan 31;10:e12731. doi: 10.7717/peerj.12731. eCollection 2022.
肝细胞癌监测:当前最佳实践和未来方向。
Gastroenterology. 2019 Jul;157(1):54-64. doi: 10.1053/j.gastro.2019.02.049. Epub 2019 Apr 12.
4
Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades.过去四十年来肺癌患者的发病率、治疗情况及生存率趋势。
Cancer Manag Res. 2019 Jan 21;11:943-953. doi: 10.2147/CMAR.S187317. eCollection 2019.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target.胶原蛋白1A1(COL1A1)促进乳腺癌转移,是一个潜在的治疗靶点。
Discov Med. 2018 May;25(139):211-223.
7
Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.基于前列腺特异性抗原的前列腺癌筛查:美国预防服务工作组的证据报告和系统评价。
JAMA. 2018 May 8;319(18):1914-1931. doi: 10.1001/jama.2018.3712.
8
COL1A1 promotes metastasis in colorectal cancer by regulating the WNT/PCP pathway.COL1A1 通过调控 WNT/PCP 通路促进结直肠癌转移。
Mol Med Rep. 2018 Apr;17(4):5037-5042. doi: 10.3892/mmr.2018.8533. Epub 2018 Feb 1.
9
Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.通过生物信息学分析对非小细胞肺癌进行靶基因筛选及预后价值评估
Gene. 2018 Mar 20;647:306-311. doi: 10.1016/j.gene.2018.01.003. Epub 2018 Jan 3.
10
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.GEPIA:一个用于癌症和正常基因表达谱分析及交互式分析的网络服务器。
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102. doi: 10.1093/nar/gkx247.